Fusemachines (FUSE) shares CEO interview, 2025 milestones and 2026 initiatives

Rhea-AI Filing Summary

Fusemachines Inc. reported that its Chief Executive Officer, Dr. Sameer Maskey, participated in an interview on social media platform X (formerly Twitter) on December 17, 2025. The company is sharing a transcript of this interview, along with a press release and a CEO letter that summarize key milestones achieved in 2025 and outline initiatives planned for 2026. These materials are being provided as exhibits for informational purposes under a Regulation FD disclosure and are not treated as formally filed financial statements or incorporated into other regulatory reports unless specifically referenced.

false 0002033383 0002033383 2025-12-17 2025-12-17 0002033383 FUSE:CommonStockParValue0.0001PerShareMember 2025-12-17 2025-12-17 0002033383 FUSE:WarrantsToPurchaseSharesOfCommonStockMember 2025-12-17 2025-12-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported) December 17, 2025

FUSEMACHINES INC.

(Exact name of registrant as specified in its charter)

Delaware		001-42909		98-1602789
(State or other jurisdiction of incorporation or organization)		(Commission File Number)		(I.R.S. Employer Identification Number)

251 West 30th Street, 5th Floor

New York. New York 10001

(Address of principal executive offices and zip code)

(347) 212-5075

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.0001 per share		FUSE		Nasdaq Stock Market LLC
Warrants to purchase shares of Common Stock		FUSEW		Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01 Regulation FD Disclosure.

On December 17, 2025, Dr. Sameer Maskey, Chief Executive Officer of Fusemachines Inc. (the “Company”) was interviewed on social media platform X (formerly known as Twitter). A transcript of this interview is furnished herewith as Exhibit 99.1.

On December 18, 2025, the Company issued a press release summarizing the Company’s milestones in 2025 and initiatives for 2026 that were discussed during the interview. A copy of this press release is furnished herewith as Exhibit 99.2. A copy of a letter that was published by the CEO of the Company describing these milestones and initiatives is furnished herewith as Exhibit 99.3.

The information furnished pursuant to this Item 7.01, including Exhibits 99.1, 99.2 and 99.3, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Exhibit Number		Description
99.1		Transcript of Dr. Sameer Maskey Interview, dated December 17, 2025
99.2		Press Release, dated December 18, 2025
99.3		CEO Letter, dated December 18, 2025
104		Cover Page Interactive Data File (embedded within the Inline XBRL document.)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: December 18, 2025	FUSEMACHINES INC.
	By:	/s/ Christine Chambers
		Christine Chambers
		Chief Financial Officer

FAQ

What did Fusemachines Inc. (FUSE) disclose in this 8-K filing?

Fusemachines Inc. disclosed that its CEO, Dr. Sameer Maskey, was interviewed on X (formerly Twitter) on December 17, 2025, and that the company is furnishing a transcript of the interview, a press release, and a CEO letter summarizing 2025 milestones and 2026 initiatives.

Which materials are included as exhibits in Fusemachines (FUSE) December 2025 disclosure?

The exhibits include a transcript of Dr. Maskey’s interview (Exhibit 99.1), a press release dated December 18, 2025 (Exhibit 99.2), a CEO letter dated December 18, 2025 (Exhibit 99.3), and the cover page interactive data file (Exhibit 104).

Are the Fusemachines (FUSE) CEO interview and related materials considered filed with the SEC?

No. The company states that the information in this Regulation FD disclosure, including Exhibits 99.1, 99.2, and 99.3, is furnished and not deemed filed under Section 18 of the Exchange Act or incorporated by reference into other filings unless specifically referenced.

What topics are covered in the Fusemachines (FUSE) press release and CEO letter?

The press release and CEO letter summarize the company’s milestones in 2025 and initiatives for 2026 that were discussed during Dr. Maskey’s interview on X.

Who signed the December 2025 Fusemachines (FUSE) disclosure?

The report was signed on behalf of Fusemachines Inc. by Christine Chambers, the company’s Chief Financial Officer.

On which exchange are Fusemachines (FUSE) securities listed?

Fusemachines Inc.’s common stock, par value $0.0001 per share, trades on the Nasdaq Stock Market LLC under the symbol FUSE, and its warrants to purchase shares of common stock trade under the symbol FUSEW.